AMBER PEOPLES: Open Payments
NPI 1003370362 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$822 in 39 payments from 14 companies in 2025. Trend: 2023 $222 · 2024 $873 · 2025 $822
Food & beverage: $822
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 19 | $381 |
| Insmed, Inc. | 3 | $69 |
| Grifols USA, LLC | 2 | $60 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $53 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $46 |
| Inspire Medical Systems, Inc. | 2 | $34 |
| GENZYME CORPORATION | 2 | $28 |
| ANI Pharmaceuticals, Inc. | 1 | $27 |
| Merck Sharp & Dohme LLC | 1 | $25 |
| United Therapeutics Corporation | 1 | $25 |
Products named: NUCALA, TRELEGY ELLIPTA, Arikayce, Prolastin-C Liquid, GLASSIA, OFEV, INSPIRE, DUPIXENT.
Industry payments across TX — which companies pay providers there.
